Product/Composition:- | Fluphenazine IM Injection |
---|---|
Strength:- | 25 mg/mL |
Form:- | Long-Acting Intramuscular Injection |
Reference Brands:- | Prolixin Decanoate(US); Fluphenazine Decanoate(EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Fluphenazine IM injection is a typical antipsychotic that works by blocking dopamine D2 receptors in the brain, helping to reduce psychotic symptoms like hallucinations, delusions, and agitation. It is primarily used to treat schizophrenia and other chronic psychoses, especially in patients with poor medication adherence.
Fluphenazine IM injection, available in both short-acting and long-acting (decanoate) formulations, is FDA-approved in the United States for the treatment of chronic schizophrenia. In the EU, it is approved in select markets under national procedures. Regulatory submissions must meet GMP standards, ensure accurate dosing for depot formulations, and include safety data addressing extrapyramidal symptoms and neuroleptic malignant syndrome. EU applications must align with local pharmacovigilance requirements and psychiatric labeling standards. For global buyers seeking dossier-ready Fluphenazine IM injections and to explore other dosage forms and suppliers, visit Pharmatradz.com — your reliable B2B pharma sourcing platform.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications